Esculon, Inc. — Form D/A
Esculon, Inc. of OMAHA, NE, a company, filed a Form D amendment with the SEC on 2017-06-19. The offering totals $2.5M, of which $1.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-06-19
- Form: D/A
- Accession: 0001709643-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $1.6M
- Remaining: $970K
- Investors: 14
- Date of first sale: 2017-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-288997
Issuer
- Name: Esculon, Inc.
- CIK: 0001709643
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 3929 Harney Street, OMAHA, NE, 68198
- Phone: 402-417-0740
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| ALAN CHESLER | Director | San Antonio, TX |
| Carter Meyer | Director | South San Francisco, CA |
| Evan Luxon | Director | OMAHA, NE |
| Deepak Gangahar | Director | Omaha, NE |
| Danial Burnett | Director | San Francisco, CA |
Other filings by this issuer (2)
More